Brian Loggie, M.D., ventured into uncharted waters when in the 1990s he pioneered a mesothelioma treatment often referred to as heated intraperitoneal chemotherapy, or heated chemotherapy.
Excellence in Research
20+ Years of Experience
Hyperthermic Intraperitoneal Chemotherapy
It was early in Loggie’s medical career that he helped develop the new cancer treatment that combined surgery with the application of heated chemotherapy drugs. The benefits were immediate. The heat made the drugs more effective in killing the various kinds of cancer. As a result, the procedure is now widely used.
Almost 20 years later, he was taking chances again – and seeing immediate results.
Get help connecting with Dr. Loggie and find the treatment that's best for you.Get Help Now
Loggie, professor of surgery and director of the Cancer Biology Program at Creighton University Medical Center in Omaha, Nebraska, led a team of doctors and nurses to Haiti immediately following the devastating earthquake of 2010.
The team was in Haiti for 11 days, working 14-hour shifts of trauma surgery under harsh, often deplorable conditions. They repaired orthopedic injuries, treated open and infected fractures, and amputated limbs, all to save lives.
Loggie returned with a new enthusiasm for his practice, treating and studying peritoneal carcinomatosis and peritoneal mesothelioma.
Loggie has authored or co-authored many articles and papers detailing treatments he has developed, many detailing the research of peritoneal mesothelioma.
Peritoneal mesothelioma is a rare form of the disease, representing just 20 percent of all mesothelioma cases. It develops in the lining of the abdominal cavity and is directly related to the inhalation or ingestion of asbestos.
Before Dr. Loggie joined the team at Creighton University School of Medicine, the hospital had no Division of Surgical Oncology – Loggie founded the program in 2002.
Loggie earned his medical degree from McGill University, in Montreal, Canada. His post-graduate training included an internship with the Department of Surgery at Montreal General Hospital in Montreal, where he later did his residency.
Loggie’s publications focus on malignant peritoneal mesothelioma and other peritoneal cancers, as well as treatment methods for these illnesses. Loggie’s articles have been published in journals such as the Annals of Surgical Oncology and the World Journal of Surgical Oncology.
Disclaimer: Dr. Brian W. Loggie has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More